MAXIDEX Eye drops, suspension

Product name and form

MAXIDEX 0.1% w/v, eye drops, suspension.

Pharmaceutical Form

Eye drops, suspension.

Qualitative and quantitative composition

Dexamethasone 0.1% w/v.

Excipient with known effect in suspension:

Benzalkonium Chloride 0.01% w/v.

For the full list excipients, see section 6.1.

List of Excipients

Sodium phosphate
Polysorbate 80
Disodium edetate
Sodium chloride
Benzalkonium chloride
Hypromellose
Citric acid
Purified water

Pack sizes and marketing

Drop-Tainer – 5ml and 10ml Natural Low Density Polyethylene Bottles and Plugs.

Polystyrene or Polypropylene cap.

Marketing authorization holder

Novartis Pharmaceuticals UK Limited, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom

Marketing authorization dates and numbers

PL 00101/0999

28/09/1990 / 17/09/2003

Drugs

Drug
Countries
Australia, Brazil, Canada, Cyprus, Spain, France, Hong Kong, Ireland, Lithuania, New Zealand, Singapore, United Kingdom, United States